June 16, 2017

Cutting Edge Science Meeting Series to End the Opioid Crisis

Participant List - Development of Safe, Effective, and Non-Addictive Pain Treatments

Participant List

James M. Anderson, M.D., Ph.D.
Director
NIH Division of Program Coordination, Planning, and Strategic Initiatives National Institutes of Health
U.S. Department of Health & Human Services

Christopher P. Austin, M.D.
Director National Center for Advancing Translational Sciences
National Institutes of Health
U.S. Department of Health & Human Services

Rita Balice-Gordon, Ph.D.
Global Head
Neuroscience Therapeutic Area
Sanofi, Inc.

James Barrett, Ph.D.
Professor
Department of Neurology
Drexel University College of Medicine

Brian Campbell, Ph.D.
Vice President of Pharmacology
MindImmune Therapeutics, Inc.
George & Anne Ryan Institute for Neuroscience
University of Rhode Island

Marc Caron, Ph.D.
James B. Duke Professor
Department of Cell Biology
Duke University

Joseph Chin, M.D.
Deputy Director
Coverage and Analysis Group
Center for Clinical Standards and Quality
Centers for Medicare & Medicaid Services
U.S. Department of Health & Human Services

Francis S. Collins, M.D., Ph.D.
Director
National Institutes of Health
U.S. Department of Health & Human Services

Penney Cowan
Founder and CEO
American Chronic Pain Association

Katherine Dawson, M.D.
‎Vice President
Pain, Neuromuscular & Rare Diseases
Late Stage Clinical Development
Biogen

Stephen Doberstein, Ph.D.
Senior Vice President and Chief Scientific
Officer Nektar Therapeutics

John Dunlop, Ph.D.
Vice President
Neuroscience Discovery
Amgen

Robert Dworkin, Ph.D.
Professor
Departments of Anesthesiology, Neurology, and Psychiatry
School of Medicine and Dentistry
University of Rochester Medical Center

Julia Finkel, M.D.
Initiative Lead and Director of R&D Pain Medicine
The Sheikh Zayed Institute for Pediatric Surgical Innovation
Children’s National Health System
Professor of Anesthesiology, Pediatrics and Critical Care Medicine
The George Washington University

Christopher M. Flores, Ph.D.
Head
Emerging Science and Innovation Strategy
Johnson & Johnson Consumer Inc.

Fabrizio Gasparini, Ph.D.
Director
Novartis Institutes for Biomedical Research

Bruce Hammock, Ph.D.
Distinguished Professor
Department of Entomology
University of California, Davis
Founder and CEO
EicOsis Human Health

Franz Hefti, Ph.D.
Chief Operations Officer
Proclara Biosciences

Sharon Hertz, M.D.
Division Director
Division of Anesthesia, Analgesia, and Addiction Products
U.S. Food and Drug Administration
U.S. Department of Health & Human Services

Elizabeth Hillman, Ph.D.
Professor of Biomedical Engineering and Radiology
Investigator, Mortimer B. Zuckerman Mind Brain Behavior Institute
Kavli Institute for Brain Science
Columbia University

Walter Koroshetz, M.D.
Director
National Institute of Neurological Disorders and Stroke
National Institutes of Health

Don Kyle, Ph.D.
Vice President
Discovery Research and Non-Clinical Development
Purdue Pharma

Min Li, Ph.D.
Senior Vice President
Global Head
Neuroscience Therapeutic Area Unit GSK

Richard Malamut, M.D.
Chief Medical Officer and Senior Vice President
Research & Development
Avanir Pharmaceuticals, Inc.

Mark A. Mintun, M.D.
Vice-President
Pain Research and Development Eli Lilly & Co
President and Chief Medical Officer
Avid Radiopharmaceuticals, Inc. (a wholly owned subsidiary of Eli Lilly & Co.)

Jose Moron-Concepcion, Ph.D.
Associate Professor
Departments of Anesthesiology and Neuroscience
Washington University Pain Center
Washington University School of Medicine

Mark Namchuk, Ph.D.
Senior Vice President, Research
Non-Clinical and Pharmaceutical Development Alkermes

Paul Negulescu, Ph.D.
Senior Vice President, Research
Vertex Pharmaceuticals

Steven D. Passik, Ph.D.
Vice President, Scientific Affairs, Education and Policy
Collegium Pharmaceuticals

Linda L. Porter, Ph.D.
Director Office of Pain Policy
Division of Extramural Activities
Office of the Director
National Institute of Neurological Disorders and Stroke
National Institutes of Health

Edward Roberts, Ph.D.
Professor Molecular Medicine
Scripps Research Institute

Brian Roth, M.D., Ph.D.
Distinguished Professor of Protein Therapeutics
and Translational Proteomics Department of Pharmacology
University of North Carolina, Chapel Hill

Friedhelm Sandbrink, M.D.
Department of Veterans Affairs
Washington, DC VA Medical Center

William Schmidt, Ph.D.
Chief Medical Officer
Ensysce Biosciences Inc.

David Soergel, M.D.
Vice President
Clinical Development
Trevena, Inc.

Lawrence A. Tabak, D.D.S., Ph.D.
Principal Deputy Director
National Institutes of Health
U.S. Department of Health & Human Services

Douglas Throckmorton, M.D.
Deputy Center Director for Regulatory Programs
Center for Drug Evaluation and Research
Office of Medical Products and Tobacco
U.S. Food and Drug Administration
U.S. Department of Health & Human Services

Kenneth Verburg, Ph.D.
Senior Vice President & Chief Development Officer
Neuroscience and Pain
Pfizer

Nora D. Volkow, M.D.
Director
National Institute on Drug Abuse
National Institutes of Health

David Wholley, M.Phil.
Director, Research Partnerships
NIH Foundation

Janet Woodcock, M.D.
Director
Center for Drug Evaluation and Research
U.S. Food and Drug Administration
U.S. Department of Health & Human Services

This page last reviewed on November 21, 2017